Veeva Systems (NYSE:VEEV) Price Target Lowered to $235.00 at Barclays

Veeva Systems (NYSE:VEEV) had its price target dropped by stock analysts at Barclays from $250.00 to $235.00 in a report issued on Thursday,Benzinga reports. The firm currently has an “overweight” rating on the technology company’s stock. Barclays‘s price objective points to a potential upside of 31.51% from the stock’s current price.

A number of other brokerages have also recently commented on VEEV. Wells Fargo & Company reaffirmed an “overweight” rating and set a $320.00 price objective (up from $317.00) on shares of Veeva Systems in a research note on Thursday. Canaccord Genuity Group decreased their price objective on Veeva Systems from $280.00 to $235.00 and set a “hold” rating for the company in a research note on Thursday, March 5th. Morgan Stanley lifted their price objective on Veeva Systems from $205.00 to $215.00 and gave the stock an “equal weight” rating in a research note on Thursday, March 5th. Raymond James Financial reaffirmed an “outperform” rating and set a $225.00 price objective on shares of Veeva Systems in a research note on Thursday. Finally, TD Cowen decreased their price objective on Veeva Systems from $380.00 to $300.00 and set a “buy” rating for the company in a research note on Thursday, March 5th. Seventeen analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $260.83.

Veeva Systems Stock Down 2.3%

Shares of Veeva Systems stock opened at $178.69 on Thursday. Veeva Systems has a 12 month low of $148.05 and a 12 month high of $310.50. The business has a fifty day simple moving average of $166.29 and a 200 day simple moving average of $196.71. The stock has a market cap of $29.19 billion, a PE ratio of 33.03, a price-to-earnings-growth ratio of 0.81 and a beta of 0.95.

Veeva Systems (NYSE:VEEV) last announced its quarterly earnings data on Wednesday, June 3rd. The technology company reported $2.24 EPS for the quarter, topping analysts’ consensus estimates of $2.14 by $0.10. Veeva Systems had a return on equity of 13.80% and a net margin of 28.44%.The business had revenue of $882.95 million during the quarter, compared to analysts’ expectations of $857.73 million. During the same period in the previous year, the firm earned $1.97 earnings per share. The firm’s quarterly revenue was up 16.3% compared to the same quarter last year. Veeva Systems has set its FY 2027 guidance at 9.050-9.050 EPS and its Q2 2027 guidance at 2.210-2.220 EPS. Analysts expect that Veeva Systems will post 6.45 EPS for the current fiscal year.

Insider Transactions at Veeva Systems

In related news, Director Priscilla Hung sold 750 shares of the stock in a transaction that occurred on Thursday, April 30th. The stock was sold at an average price of $155.64, for a total transaction of $116,730.00. Following the completion of the sale, the director directly owned 3,253 shares of the company’s stock, valued at approximately $506,296.92. This represents a 18.74% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 10.60% of the company’s stock.

Institutional Trading of Veeva Systems

Large investors have recently bought and sold shares of the business. SHP Wealth Management bought a new stake in Veeva Systems during the 4th quarter worth approximately $26,000. Board of the Pension Protection Fund bought a new stake in Veeva Systems during the 4th quarter worth approximately $27,000. Raiffeisen Bank International AG bought a new stake in Veeva Systems during the 3rd quarter worth approximately $28,000. Newbridge Financial Services Group Inc. boosted its position in shares of Veeva Systems by 322.6% during the fourth quarter. Newbridge Financial Services Group Inc. now owns 131 shares of the technology company’s stock worth $29,000 after buying an additional 100 shares during the period. Finally, Activest Wealth Management boosted its position in shares of Veeva Systems by 3,175.0% during the fourth quarter. Activest Wealth Management now owns 131 shares of the technology company’s stock worth $29,000 after buying an additional 127 shares during the period. 88.20% of the stock is owned by institutional investors.

More Veeva Systems News

Here are the key news stories impacting Veeva Systems this week:

• Positive Sentiment: Veeva reported Q1 revenue of about $882.9 million and adjusted EPS of $2.24, both ahead of estimates, showing continued demand and profitability improvement. Veeva Systems (VEEV) Q1 Earnings and Revenues Surpass Estimates
• Positive Sentiment: Management issued Q2 revenue guidance of roughly $902 million-$905 million and EPS guidance of $2.21-$2.22, both above consensus, signaling confidence in near-term growth. Veeva Announces Fiscal 2027 First Quarter Results
• Positive Sentiment: Veeva highlighted AI innovations during the earnings call, which may support future product adoption and help the company deepen its competitive position in life sciences software. Veeva Systems Inc (VEEV) Q1 2027 Earnings Call Highlights: Surpassing Revenue Guidance and Unveiling AI Innovations
• Neutral Sentiment: Several summaries of the results emphasized that the quarter’s headline numbers were strong, but investors are still parsing the full transcript and details behind the outlook. Veeva Systems Inc. (VEEV) Q1 2027 Earnings Call Transcript
• Negative Sentiment: Despite the beat-and-raise report, some coverage noted the shares slipped after the announcement, suggesting the market may have been positioned for strong results or is focused on valuation and broader market sentiment. Veeva Shares Slip Despite Beating Q1 Estimates: Details

About Veeva Systems

Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.